• Prevotella copri Promotes Breast Cancer via IPyA Depletion a

  2026-06-30

  A 2024 study uncovers how Prevotella copri, enriched in the gut microbiota of breast cancer patients, accelerates tumor progression by depleting host indole-3-pyruvic acid (IPyA) and inactivating AMPK via UHRF1-mediated regulation. This work highlights a direct microbiota–metabolite–tumor link, suggesting opportunities for metabolic and microbial intervention in breast cancer.

• Toremifene in Breast Cancer: 20 Years of Endocrine Therapy E

  2026-06-30

  This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator, for hormone-sensitive breast cancer. The study contextualizes how biomarker-driven personalization and molecular profiling have transformed endocrine therapy, and highlights implications for both clinical and preclinical research.

• Triptolide (PG490): Advanced Workflows for Cancer Research

  2026-06-29

  Triptolide (PG490) from APExBIO offers nanomolar potency for inhibiting cell proliferation, migration, and transcriptional activity in cancer and immunology models. This article delivers applied protocols, troubleshooting strategies, and actionable insights to maximize experimental reproducibility and mechanistic depth in cancer research workflows.

• High Viscosity Promotes P-gp–Mediated Chemoresistance in Can

  2026-06-29

  This study reveals how increased extracellular fluid viscosity in the tumor microenvironment triggers chemoresistance in cancer cells by upregulating P-glycoprotein (P-gp) expression via a mechanotransduction pathway. These findings provide a mechanistic link between tumor biomechanics and transporter-mediated drug resistance, offering new experimental angles for overcoming chemoresistance.

• Repurposing Vitamins as SARS-CoV-2 3CL Protease Inhibitors

  2026-06-28

  Eskandari et al. (2022) systematically evaluated the potential of natural vitamins to inhibit SARS-CoV-2 main protease (3CLpro) and spike protein RBD using molecular docking and simulation. Their findings highlight a rational, structure-based approach to identifying accessible compounds for antiviral therapeutics research with direct implications for COVID-19 intervention.

• Tacrine Hydrochloride Hydrate in Neurodegenerative Disease M

  2026-06-27

  Tacrine hydrochloride hydrate (tetrahydroaminacrine) delivers unique value as a benchmark cholinesterase inhibitor and neuroprotective agent in Alzheimer's disease research. This article explores advanced workflow strategies, protocol optimization, and troubleshooting tips, drawing from recent innovations and evidence-backed insights to maximize experimental reliability and translational relevance.

• Strategic mRNA Synthesis: HyperScribe™ Kit Plus in Precision

  2026-06-26

  Explore how the HyperScribe Co-transcription mRNA Synthesis Kit Plus (ARCA, T7) advances ARCA capped mRNA synthesis for next-generation immunotherapy. This article delivers new scientific insights into assay design, translational efficiency, and practical workflow choices, setting it apart from previous coverage.

• Thiamet G: O-GlcNAcase Inhibitor Workflows in Disease Models

  2026-06-26

  Thiamet G empowers researchers to precisely modulate O-GlcNAcylation, unlocking advanced workflows for neurodegeneration, oncology, and placental biology. Its potency, selectivity, and robust solubility streamline experimental design, enabling breakthrough insights into cellular stress, protein phosphorylation, and disease modulation.

• Tamsulosin in Urological Disease Research: Applied Protocols

  2026-06-25

  Tamsulosin’s selectivity for α₁A-adrenergic receptors enables targeted, high-fidelity modeling of smooth muscle relaxation in urological research and GPCR signaling studies. This guide translates the latest evidence and workflow enhancements into actionable steps, boosting reproducibility and data quality for both bench and translational scientists.

• AP20187: Chemical Inducer of Dimerization for Gene Control

  2026-06-25

  AP20187 is a validated chemical inducer of dimerization enabling precise, conditional control of protein–protein interactions in gene expression systems. Its high solubility, cell permeability, and regulatory utility make it essential for advanced research in metabolic regulation and conditional gene therapy.

• Clozapine N-oxide: Precision Chemogenetics for Neuronal Modu

  2026-06-24

  Clozapine N-oxide (CNO) unlocks unparalleled control over neuronal circuits in vivo, enabling researchers to non-invasively modulate activity with designer receptors. This guide details advanced workflows and real-world troubleshooting to maximize CNO’s utility as a neuroscience research tool.

• Metabolic Intervention Enhances Ferroptosis and Cuproptosis

  2026-06-23

  This study introduces a nanosystem-based strategy that synchronously amplifies ferroptosis and cuproptosis in tumor cells by targeting glycolysis and NAD+ metabolism. The dual-pathway intervention not only strengthens regulated cell death but also remodels the tumor immune microenvironment, offering a robust foundation for advanced anti-tumor therapies.

• Minocycline HCl in Translational Neuroinflammation: From Mec

  2026-06-23

  This thought-leadership article explores Minocycline HCl’s dual role as an antimicrobial and a neuroprotective compound, with a focus on its mechanistic inhibition of microglial activation and apoptosis in translational models. Drawing on new evidence from retinal amyloid clearance studies and positioning APExBIO’s Minocycline HCl as a gold-standard research tool, the article delivers actionable guidance for researchers navigating the interface of inflammation, neurodegeneration, and innovative experimental design.

• Fluorouracil: Mechanistic Insights and Translational Strateg

  2026-06-22

  This thought-leadership article explores the evolving role of Fluorouracil (Adrucil) in solid tumor research, integrating recent mechanistic findings with strategic guidance for translational scientists. We dissect its action as a thymidylate synthase inhibitor, highlight new prognostic markers in breast cancer, and chart advanced workflows to maximize antitumor efficacy and interpretability. The discussion leverages recent bioinformatics and preclinical data, with a focus on APExBIO's validated Fluorouracil for credible, reproducible research.

• Omega-3 PUFAs Prevent Sevoflurane-Induced Neurotoxicity in N

  2026-06-22

  A recent study demonstrates that omega-3 polyunsaturated fatty acids (PUFAs) protect neonatal mice from cognitive and fine motor deficits caused by repeated sevoflurane anesthesia. This protective effect is mediated by enhanced glymphatic clearance of phosphorylated tau, highlighting new mechanistic pathways and potential interventions in pediatric neurotoxicity.

16328 records 1/1089 page Next 12345 下5页 Last page